Additional Titles: Острые отравления метадоном (дольфином) (обзор)

المؤلفون: Georgy Livanov A.; I. I. Dzhanelidze Saint-Petersburg Research Institute of Emergency Medicine, Alexander Loladze T.; I. I. Dzhanelidze Saint-Petersburg Research Institute of Emergency Medicine, Bair Batotsyrenov V.; I. I. Dzhanelidze Saint-Petersburg Research Institute of Emergency Medicine, Alexey Lodyagin N.; I. I. Dzhanelidze Saint-Petersburg Research Institute of Emergency Medicine, Sergey Glushkov I.; I. I. Dzhanelidze Saint-Petersburg Research Institute of Emergency Medicine, Tatiana Kharitonova V.; I. I. Dzhanelidze Saint-Petersburg Research Institute of Emergency Medicine, Alexandra Ivanova A.; I. I. Dzhanelidze Saint-Petersburg Research Institute of Emergency Medicine, Dmitry Baranov V.; I. I. Dzhanelidze Saint-Petersburg Research Institute of Emergency Medicine, Anna Antonova M.; I. I. Dzhanelidze Saint-Petersburg Research Institute of Emergency Medicine, Г. Ливанов А.; Санкт-Петербургский НИИ скорой помощи им. И. И. Джанелидзе, А. Лоладзе Т.; Санкт-Петербургский НИИ скорой помощи им. И. И. Джанелидзе, Б. Батоцыренов В.; Санкт-Петербургский НИИ скорой помощи им. И. И. Джанелидзе, А. Лодягин Н.; Санкт-Петербургский НИИ скорой помощи им. И. И. Джанелидзе, С. Глушков И.; Санкт-Петербургский НИИ скорой помощи им. И. И. Джанелидзе, Т. Харитонова В.; Санкт-Петербургский НИИ скорой помощи им. И. И. Джанелидзе, А. Иванова А.; Санкт-Петербургский НИИ скорой помощи им. И. И. Джанелидзе, Д. Баранов В.; Санкт-Петербургский НИИ скорой помощи им. И. И. Джанелидзе, А. Антонова М.; Санкт-Петербургский НИИ скорой помощи им. И. И. Джанелидзе

المصدر: General Reanimatology; Том 13, № 3 (2017); 48-63; Общая реаниматология; Том 13, № 3 (2017); 48-63; 2411-7110; 1813-9779; 10.15360/1813-9779-2017-3

مصطلحات الفهرس: acute poisoning; opioids; methadone; heroin; hypoxia; naloxone; antihypoxant; cytoflavin, острые отравления; опиоиды; метадон; героин; гипоксия; налоксон; субстратные антигипоксанты; цитофлавин, info:eu-repo/semantics/article, info:eu-repo/semantics/publishedVersion

URL: https://www.reanimatology.com/rmt/article/view/1592/1094
https://www.reanimatology.com/rmt/article/view/1592/1129
https://www.reanimatology.com/rmt/article/view/1592/1094
https://www.reanimatology.com/rmt/article/view/1592/1129
Лужников Е.А., Костомарова Л.Г. Острые отравления. Руководство для врачей. М.: Медицина; 2000: 434.
Лоладзе А.Т., Ливанов Г.А., Батоцыренов Б.В., Коваленко А.Л., Лодягин А.Н., Глушков С.И., Баранов Д.В., Антонова А.М., Харитонова Т.В. Острые отравления диацетилморфином (героином) (обзор). Общая реаниматология. 2016; 12 (6): 64–81. http://dx.doi.org/ 10.15360/1813-9779-2016-6-64-81
Батоцыренов Б.В., Ливанов Г.А., Андрианов А.Ю., Васильев С.А., Кузнецов О.А. Особенности клинического течения и коррекция метаболических расстройств у больных с тяжелыми отравлениями метадоном. Общая реаниматология. 2013; 9 (2): 18–22. http://dx. doi.org/10.15360/1813-9779-2013-2-18
Methadone diversion, abuse, and misuse: deaths increasing at alarming rate. National Drug Intelligence Center, U.S. Department of Justice. Washington, DC, USA, 2007. https://www.justice.gov/archive/ndic/ pubs25/25930/index.htm
Marcus S.M. Accidental death from take home methadone maintenance doses: a report of a case and suggestions for prevention. Child Abuse Negl. 2011; 35 (1): 1–2. http://dx.doi.org/10.1016/j.chi- abu.2010.08.003. PMID: 21316105
Buster M.C., van Brussel G.H., van den Brink W. An increase in overdose mortality during the first 2 weeks after entering or re-entering methadone treatment in Amsterdam. Addiction. 2002: 97 (8): 993–1001. https://doi.org/10.1046/j.1360-0443.2002.00179.x. PMID: 12144602
Elzey M.J., Barden S.M., Edwards E.S. Patient characteristics and out- comes in unintentional, non-fatal prescription opioid overdoses: a sys- tematic review. Pain Physician. 2016; 19 (4): 215–228. PMID: 27228510
Ellenhorn M.J., Barceloux D.G. Medical toxicology: diagnosis and treat- ment of human poisoning. New York, NY: Elsevier Scientific Publ. Co.; 1988: 1512.
Hoffman R., Howland M.A., Lewin N., Nelson L., Goldfrank L. Goldfrank’s Toxicologic Emergencies, 10th ed. New York, NY: McGraw-Hill; 2015: 1904.
Bockmühl M., Ehrhart G. Über eine neue Klasse von spasmolytisch und analgetisch wirkenden Verbindungen, I. Justus Liebigs Annalen der Chemie. 1949; 561 (1): 52–85.
Preston A., O’Connor S. The Methadone Handbook. 3id ed. UK: Island Press; 1996: 36.
Список наркотических средств и психотропных веществ, оборот которых в Российской Федерации запрещен в соответствии и законо- дательством РФ и международными договорами РФ (список I). http://www.yourist-ufa.ru/criminal-law-news/577-228-2281-229- 2291.html.
Gourlay D.L., Heit H.A., Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med. 2005; 6 (2): 107–112. http://dx.doi.org/10.1111/j.1526- 4637.2005.05031.x. PMID: 15773874
Вергейчик Т.Х. Токсикологическая химия. М.: МЕДпресс-информ; 2009: 200.
Reisine T., Pasternak G. Opioid analgesics and antagonists. In: Limbird L.E., Hardman J.G. (eds.). Goodman and Gilman’s The Pharmacologic Basis of Therapeutics. 9th ed. NewYork: McGraw-Hill; 1996: 521–555.
Eap C.B., Buclin T., Baumann P. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin. Pharmacokinet. 2002; 41 (14): 1153–1193. http://dx.doi.org/ 10.2165/00003088-200241140-00003. PMID: 12405865
de Castro J., Aguirre C., Rodríguez Sasiaín J.M., Gómez E., Garrido M.J., Calvo R. The effect of changes in gastric pH induced by omeprazole on the absorption and respiratory depression of methadone. Biopharm. Drug Dispos. 1996; 17 (7): 551–563. http://dx.doi.org/10.1002/ (SICI)1099-081X(199610)17:7<551::AID-BDD967>3.0.CO;2-1. PMID: 8894114
Ferrari A., Coccia C.P., Bertolini A., Sternieri E. Methadone–metabolism, pharmacokinetics and interactions. Pharmacol. Res. 2004; 50 (6): 551–559. http://dx.doi.org/10.1016/j.phrs.2004.05.002. PMID: 15501692
Dale O., Sheffels P., Kharasch E.D. Bioavailabilities of rectal and oral methadone in healthy subjects. Br. J. Clin. Pharmacol. 2004; 58 (2): 156–162. http://dx.doi.org/10.1111/j.1365-2125.2004.02116.x. PMID: 15255797
Grabinski P.Y., Kaiko R.F., Rogers A.G., Houde R.W. Plasma levels and analgesia following deltoid and gluteal injections of methadone and morphine. J. Clin. Pharmacol. 1983; 23 (1): 48–55. https://doi.org/ 10.1002/j.1552-4604.1983.tb02704.x. PMID: 6841658
de Vos J.W., Geerlings P.J., van den Brink W., Ufkes J.G., van Wilgenburg H. Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts. Eur. J. Clin. Pharmacol. 1995; 48 (5): 361–366. https://doi.org/10.1007/BF00194951. PMID: 8641323
Blinick G., Inturrisi C.E., Jerez E., Wallach R.C. Amniotic fluid methadone in women maintained on methadone. Mt. Sinai J. Med. 1974; 41 (2): 254–259. PMID: 4544621
Blinick G., Inturrisi C.E., Jerez E., Wallach R.C. Methadone assays in pregnant women and progeny. Am. J. Obstet. Gynecol. 1975; 121 (5): 617–621. https://doi.org/10.1016/0002-9378(75)90461-5. PMID: 1115163
Eap C.B., Cuendet C., Baumann P. Binding of d-methadone, l- methadone, and dl-methadone to proteins in plasma of healthy volun- teers: role of the variants of alpha 1-acid glycoprotein. Clin. Pharmacol. Ther. 1990; 47 (3): 338–346. https://doi.org/10.1038/clpt.1990.37. PMID: 2311335
Wilkins J.N., Ashofteh A., Setoda D., Wheatley W.S., Huigen H., Ling W. Ultrafiltration using the AmiconMPS-1 for assessing methadone plasma protein binding. Ther. Drug Monit. 1997; 19 (1): 83–87. https://doi.org/ 10.1097/00007691-199702000-00015. PMID: 9029753
Abramson F.P. Methadone plasma protein binding: alterations in cancer and displacement from alpha 1-acid glycoprotein. Clin. Pharmacol. Ther. 1982; 32 (5): 652–658. https://doi.org/10.1038/clpt.1982.217. PMID: 7128006
Romach M.K., Piafsky K.M., Abel J.G., KhouwV., Sellers E.M. Methadone binding to orosomucoid (alpha 1-acid glycoprotein): determinant of free fraction in plasma. Clin. Pharmacol. Ther. 1981; 29 (2): 211–217. https://doi.org/10.1038/clpt.1981.34. PMID: 7193106
Malpas T.J., Darlow B.A., Lennox R., Horwood L.J. Maternal methadone dosage and neonatal withdrawal. Aust. N Z J. Obstet. Gynaecol. 1995; 35 (2): 175–177. http://dx.doi.org/10.1111/j.1479-828X.1995.tb01863.x. PMID: 7677682
Neonatal drug withdrawal. Pediatrics. 1983; 72 (6): 895–902. PMID: 6139783
Wojnar-Horton R.E., Kristensen J.H., Yapp P., Ilett K.F., Dusci L.J., Hackett L.P. Methadone distribution and excretion into breast milk of clients in a methadone maintenance programme. Br. J. Clin. Pharmacol. 1997; 44 (6): 543–547. https://doi.org/10.1046/j.1365-2125.1997. t01-1-00624.x. PMID: 9431829
McCarthy J.J., Posey B.L. Methadone levels in human milk. J. Hum. Lact. 2000; 16 (2): 115–120. https://doi.org/10.1177/089033440001600206. PMID: 11153342
Begg E.J., Malpas T.J., Hackett L.P., Ilett K.F. Distribution of R- and S- methadone into human milk during multiple, medium to high oral dos- ing. Br. J. Clin. Pharmacol. 2001; 52 (6): 681–685. https://doi.org/ 10.1046/j.0306-5251.2001.01506.x. PMID: 11736879
Beckett A.H., Taylor J.F., Casy A.F., Hassan M.M. The biotransformation of methadone in man: synthesis and identification of a major metabo- lite. J. Pharm. Pharmacol. 1968; 20 (10): 754–762.https://doi.org/ 10.1111/j.2042-7158.1968.tb09634.x. PMID: 4386743
Verebely K., Volavka J., Mulé S., Resnick R. Methadone in man: pharma- cokinetic and excretion studiesin acute and chronic treatment. Clin. Pharmacol. Ther. 1975; 18 (2): 180–190. https://doi.org/10.1002/ cpt1975182180. PMID: 1149368
Anggård E., Gunne L.M., Homstrand J., McMahon R.E., Sandberg C.G., Sullivan H.R. Disposition of methadone in methadone maintenance. Clin. Pharmacol. Ther. 1975; 17 (3): 258–266. https://doi.org/ 10.1002/cpt1975173258. PPMID: 1120392
Iribarne C., Berthou F., Baird S., Dréano Y., Picart D., Bail J.P., Beaune P., Ménez J.F. Involvement of cytochrome P450 3A4 enzyme in the N- demethylation of methadone in human liver microsomes. Chem. Res. Toxicol. 1996; 9 (2): 365–373. http://dx.doi.org/10.1021/tx950116m. PMID: 8839037
Moody D.E., Alburges M.E., Parker R.J., Collins J.M., Strong J.M. The involvement of cytochrome P4503A4 in the N-demethylation of L- alpha-acetylmethadol (LAAM), norLAAM, and methadone. Drug Metab. Dispos. 1997; 25 (12): 1347–1353. PMID: 9394023
Peng P.W., Tumber P.S., Gourlay D. Review article: perioperative pain management of patients on methadone therapy. Can. J Anaesth. 2005; 52 (5): 513–523. http://dx.doi.org/10.1007/BF03016532. PMID: 15872131
Kharasch E.D., Hoffer C., Whittington D., Sheffels P. Role of hepatic and intestinal cytochrome P450 3Aand 2B6 in the metabolism, disposition, and miotic effects of methadone. Clin. Pharmacol. Ther. 2004; 76 (3): 250–269. http://dx.doi.org/10.1016/j.clpt.2004.05.003. PMID: 15371986
Foster D.J., Somogyi A.A., Bochner F. Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4. Br. J. Clin. Pharmacol. 1999; 47 (4): 403–412. https://doi.org/10.1046/j.1365-2125.1999.00921.x. PMID: 10233205
Bertschy G., Eap C.B., Powell K., Baumann P. Fluoxetine addition to methadone in addicts: pharmacokinetic aspects. Ther. Drug Monit. 1996; 18 (5): 570–572. https://doi.org/10.1097/00007691- 199610000-00008. PMID: 8885121
Eap C.B., Bertschy G., Powell K., Baumann P. Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone. J. Clin. Psychopharmacol. 1997; 17 (2): 113–117. https://doi.org/10.1097/00004714-199704000-00010. PMID: 10950475
Gerber J.G., Rhodes R.J., Gal J. Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19. Chirality. 2004; 16 (1): 36–44. http://dx.doi.org/10.1002/chir.10303. PMID: 14628297
Wang J.S., DeVane C.L. Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro. Drug Metab. Dispos. 2003; 31 (6): 742–747. https://doi.org/10.1124/ dmd.31.6.742. PMID: 12756206
Mégarbane B., Declèves X., Bloch V., Bardin C., Chast F., Baud F.J. Case report: quantification of methadone-induced respiratory depression using toxicokinetic/toxicodynamic relationships. Crit. Care. 2007; 11 (1): R5. http://dx.doi.org/10.1186/cc5150. PMID: 17224045
Ebert B., Thorkildsen C., Andersen S., Christrup L.L., Hjeds H. Opioid analgesics as noncompetitive N-methyl-D-aspartate (NMDA) antagonists. Biochem. Pharmacol. 1998; 56 (5): 553–559. https://doi.org/ 10.1016/S0006-2952(98)00088-4. PMID: 9783723
Liu J.G., Anand K.J. Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res. Brain Res. Rev. 2001; 38 (1–2): 1–19. https://doi.org/10.1016/S0165- 0173(01)00057-1. PMID: 11750924
Mao J. NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Res. Brain Res. Rev. 1999; 30 (3): 289–304. https://doi.org/10.1016/S0165-0173(99)00020-X. PMID: 10567729
Lugo R.A., Satterfield K.L., Kern S.E. Pharmacokinetics of methadone. J. Pain Palliat. Care Pharmacother. 2005; 19 (4): 13–24. https://doi.org/ 10.1080/J354v19n04_05. PMID: 16431829
Rando J., Szari S., Kumar G., Lingadevaru H. Methadone overdose causing acute cerebellitis and multi-organ damage. Am. J. Emerg. Med. 2016; 34 (2): 343.e1-3. http://dx.doi.org/10.1016/j.ajem.2015.06.032. PMID: 26164407
Isaacson J.E., Vora N.M. Differential diagnosis and treatment of hearing loss. Am. Fam. Physician. 2003; 68 (6): 1125–1132. PMID: 14524400
Oh A.K., Ishiyama A., Baloh R.W. Deafness associated with abuse of hydrocodone/acetaminophen. Neurology. 2000; 54 (12): 2345. https://doi.org/10.1212/WNL.54.12.2345. PMID: 10881270
Ishiyama A., Ishiyama G., Baloh R.W., Evans C.J. Heroin-induced reversible profound deafness and vestibular dysfunction. Addiction. 2001; 96 (9): 1363–1364. PMID: 11683145
Shaw K.A., Babu K.M., Hack J.B. Methadone, another cause of opioid-associated hearing loss: a case report. J. Emerg. Med. 2011; 41 (6): 635–639. http://dx.doi.org/10.1016/j.jemermed.2010.11.014. PMID: 21145191
Chevillard L., Mégarbane B., Baud F.J., Risède P., Declèves X., Mager D., Milan N., Ricordel I. Mechanisms of respiratory insufficiency induced by methadone overdose in rats. Addict. Biol. 2010; 15 (1): 62–80. http://dx.doi.org/10.1111/j.1369-1600.2009.00184.x. PMID: 20002023
Swegle J.M., Wensel D.D. The safety of methadone hydrochloride. Expert Opin. Drug Saf. 2008; 7 (1): 5–8. http://dx.doi.org/10.1517/ 14740338.7.1.5. PMID: 18171310
Fone K.C., Wilson H. The effects of alfentanil and selected narcotic analgesics on the rate of action potential discharge of medullary respiratory neurones in anaesthetized rats. Br. J. Pharmacol. 1986; 89 (1): 67–76. https://doi.org/10.1111/j.1476-5381.1986.tb11121.x. PMID: 2879593
van den Hoogen R.H., Colpaert F.C. Respiratory effects of morphine in awake unrestrained rats. J. Pharmacol. Exp. Ther. 1986; 237 (1): 252–259. PMID: 3083095
Shook J.E., Watkins W.D., Camporesi E.M. Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression. Am. Rev. Respir. Dis. 1990; 142 (4): 895–909. http://dx.doi.org/10.1164/ajrccm/142.4.895. PMID: 2171388
Bailey P.L., Lu J.K., Pace N.L., Orr J.A., White J.L., Hamber E.A., Slawson M.H., Crouch D.J., Rollins D.E. Effects of intrathecal morphine on the ventilatory response to hypoxia. N. Engl. J. Med. 2000 26; 343 (17): 1228–1234. http://dx.doi.org/10.1056/NEJM200010263431705. PMID: 11071674
Pfeiffer A., Feuerstein G., Kopin I.J., Faden A.I. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats. J. Pharmacol. Exp. Ther. 1983; 225 (3): 735–741. PMID: 6306217
Zyroff J., Slovis T.L., Nagler J. Pulmonary edema induced by oral methadone. Radiology. 1974; 112 (3): 567–568. http://dx.doi.org/ 10.1148/112.3.567. PMID: 4843287
Wilson K.C., Saukkonen J.J. Acute respiratory failure from abused sub- stances. J. Intensive Care Med. 2004; 19: 183–193. http://dx.doi.org/ 10.1177/0885066604263918. PMID: 15296619
Milroy C.M., Forrest A.R.W. Methadone deaths: a toxicological analysis. J. Clin. Pathol. 2000; 53 (4): 277–281. http://dx.doi.org/10.1136/ jcp.53.4.277. PMID: 10823123
Sánchez Hernández A.M., Atienza Fernández F., Arenal Maíz A., González Torrecilla E., Puchol Calderón A., Almendral Garrote J. Torsades de pointes during methadone treatment. Rev. Esp. Cardiol. 2005; 58 (10): 1230–1232. https://doi.org/10.1157/13079918. PMID: 16238992
Chugh S.S., Socoteanu C., Reinier K., Waltz J., Jui J., Gunson K. A com- munity-based evaluation of sudden death associated with therapeutic levels of methadone. Am. J. Med. 2008; 121 (1): 66–71. http://dx. doi.org/10.1016/j.amjmed.2007.10.009. PMID: 18187075
Cruciani R.A. Methadone: to ECG or not to ECG...That is still the question. J. Pain Symptom. Manage. 2008; 36 (5): 545–552. http://dx.doi.org/10.1016/j.jpainsymman.2007.11.003. PMID: 18440771
Wedam E.F., Bigelow G.E., Johnson R.E., Nuzzo P.A., Haigney M.C. QT- interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. Arch. Intern. Med. 2007; 167 (22): 2469–2475. http://dx.doi.org/10.1001/archinte.167.22.24
PMID: 18071169 69. Walley A.Y., Doe Simkins M., Quinn E., Pierce C., Xuan Z., Ozonoff A. Opioid overdose prevention with intranasal naloxone among people who take methadone. J. Subst. Abuse Treat. 2013; 44 (2): 241–247. http://dx.doi.org/10.1016/j.jsat.2012.07.004. PMID: 22980450
Кузнецов О.А., Батоцыренов Б.В., Лодягин А.Н., Федоров А.В., Лоладзе А.Т. Острое повреждение почек при отравлениях метадоном: причины, патогенез, терапия. Наркология. 2016; 15 (8): 62–67.
Polettini A., Groppi A., Vignali C., Montagna M. Fully-automated systematic toxicological analysis of drugs, poisons, and metabolites in whole blood, urine, and plasma by gas chromatography-full scan mass spec- trometry. J. Chromatogr. B Biomed. Sci. Appl. 1998; 713 (1): 265–279. http://doi.org/10.1016/S0378-4347(98)00062-0. PMID: 9700563
Менделевич В.Д. Метадоновая зависимость и программа метадоновой поддерживающей терапии. Наркология. 2007; 6 (9): 67–72.
Nielsen S., Larance B., Degenhardt L., Gowing L., Kehler C., Lintzeris N. Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database Syst. Rev. 2016; 9 (5): CD011117. http://dx.doi.org/10.1002/14651858.CD011117.pub2. PMID: 27157143
Mattick R.P., Kimber J., Breen C., Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst. Rev. 2008; 16; (2): CD002207. http://dx.doi.org/10.1002/14651858.CD002207.pub2. PMID: 15266465
Vignali C., Stramesi C., Morini L., Pozzi F., Groppi A. Methadone-related deaths. A ten year overview. Forensic. Sci. Int. 2015; 257: 172–176. http://dx.doi.org/10.1016/j.forsciint.2015.08.017. PMID: 26360592
Надеждин А.В. Перспективы внедрения «заместительной терапии» у больных опийной наркоманией в России. Наркология. 2002; 1 (2): 42–44.
Иванец Н.Н., Альтшулер В.Б. «Заместительная терапия» наркомании метадоном и другими опиоидными наркотиками: происхождение, суть и тенденции. Вопросы наркологии. 2004; 2: 3–7.
Coffin P.O., Sullivan S.D. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann. Intern. Med. 2013; 158 (1): 1–9. http://dx.doi.org/10.7326/0003-4819-158-1-201301010- 00003. PMID: 23277895
Coffin P.O., Sullivan S.D. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities. J. Med. Econ. 2013; 16 (8): 1051–1060. http://dx.doi.org/10.3111/13696998.2013. 8110
PMID: 23730942 80. Kerr D., Kelly A.M., Dietze P., Jolley D., Barger B. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramus- cular naloxone for the treatment of suspected heroin overdose. Addiction. 2009; 104 (12): 2067–2074. http://dx.doi.org/10.1111/ j.1360-0443.2009.02724.x. PMID: 19922572
Sporer K.A., Firestone J., Isaacs S.M. Out-of-hospital treatment of opioid overdoses in an urban setting. Acad. Emerg. Med. 1996; 3 (7): 660–667. https://doi.org/10.1111/j.1553-2712.1996.tb03487.x. PMID: 8816181
Centers for Disease Control and Prevention (CDC). Community-based opioid overdose prevention programmes providing naloxone — United States, 2010. MMWR Morb. Mortal. Wkly. Rep. 2012; 61 (6): 101–105. PMID: 22337174
Burris S., Norland J., Edlin B.R. Legal aspects of providing naloxone to heroin users in the United States. Int. J. Drug Policy. 2001; 12 (3): 237–248.
Just B., Delva E., Camus Y., Lienhart A. Oxygen uptake during recovery following naloxone. Relatoinship with intraoperative heat loss. Anestheziology. 1992; 76 (1): 60–64. https://doi.org/10.1097/ 00000542-199201000-00009. PMID: 1729937
Kim H.K., Nelson L.S. Effectiveness of low dose naloxone to reverse respiratory depression in opioid intoxication. Clin. Toxicol. 2012; 50 (7): 577–578.
Лужников Е.А., Суходолова Г.Н. Клиническая токсикология. М.: МИА; 2008: 576.
Лужников Е.А., Ильяшенко К.К., Ястребова Е.В., Калянова Н.А., Епифанова Н.М., Гольдфарб Ю.С., Петров С.И., Бадалян А.В., Мелконян Ш.Л., Маткевич В.А., Суходолова Г.Н., Ливанов А.С., Ельков А.Н., Марченкова Л.В. Клиника, диагностика и лечение острых отравлений наркотиками. Методические рекомендации. М.: НИИ СП им. Н.В. Склифосовского; 2000: 12.
Шилов В.В., Батоцыренов Б.В., Васильев С.А., Шикалова И.А., Лоладзе А.Т. Коррекция неспецифических поражений при острых отравлениях наркотическими веществами из группы опиатных наркотиков у больных в критическом состоянии. Воен.-мед. журнал. 2011; 332 (11): 36–39. PMID: 22329170
Алехнович А.В., Ильяшенко К.К., Ельков А.Н., Леженина Н.Ф., Ливанов А.С. Сравнительная оценка клинической эффективности антигипоксантов у больных с острыми отравлениями психотропными препаратами. Общая реаниматология. 2009; 5 (1): 58 – 60. http://dx.doi.org/10.15360/1813-9779-2009-1-58
Ливанов Г.А., Лодягин А.Н., Батоцыренов Б.В., Лоладзе А.Т., Глушков С.И., Коваленко А.Л. Использование реамберина в комплексе интенсивной терапии острых отравлений. Клин. медицина. 2016; 94 (5): 339–346. http://dx.doi.org/10.18821/0023-2149-2016-94-5-340-347
Александрович Ю.С., Пшениснов К.В. Инфузионные антигипоксанты при критических состояниях у детей. Общая реаниматология. 2014; 10 (3): 59–74. http://dx.doi.org/10.15360/1813-9779-2014-3-59-74
Орлов Ю.П., Говорова Н.В. Роль сукцинатов при критических состояниях. Общая реаниматология. 2014; 10 (6): 65–82. http://dx.doi.org/10.15360/1813-9779-2014-6-65-82
Ивницкий Ю.Ю. Янтарная кислота в системе метаболической коррекции функционального состояния и резистентности организма. СПб: 1998; 82. 94. Александров М.В., Васильев С.А., Кузнецов О.А., Андрианов А.Ю., Шикалова И.А., Лоладзе А.Т., Батоцыренов Б.В. Использование цитофлавина в комплексе нейрометаболической терапии острой церебральной недостаточности при острых отравлениях нейротропными ядами. Клин. медицина. 2010; 88 (2): 58–61. PMID: 21105475
Kwong L.K., Sohal R.S. Substrate and site specificity of hydrogen peroxide generation in mouse mitochondria. Arch. Biochem. Biophys. 1998; 350 (1): 118–126. http://dx.doi.org/10.1006/abbi.1997.0489. PMID: 9466828
Suzuki M., Muraoka H., Kurata M., Agar N.S. Glutathione reductase activity and flavin concentration in guinea-pig tissues. Exp. Anim. 1999; 48 (3): 199–202. https://doi.org/10.1538/expanim.48.199. PMID: 10480025
Thiemermann C., Bowes J., Myint F.P., Vane J.R. Inhibition of the activity of poly (ADP ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc. Natl. Acad. Sci. USA. 1997; 94 (2): 679–683. https://doi.org/10.1073/pnas.94.2.679. PMID: 9012844
Дунаев В.В., Тишкин В.С., Евдокимов Е.И. К механизму действия рибоксина. Фармакол. токсикология. 1989; 52 (6): 56–58. PMID: 2483141